Security key
87650L103
Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)
CUSIP: 87650L103
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 20,489,091
- Total 13F value
- $350,771,070
- Share change
- +508,341
- SEC-reported price per share
- $17.12
- Number of holders
- 72
- Value change
- +$9,266,431
- Number of buys
- 34
- Number of sells
- 27
- Shares outstanding
- 43,212,246
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
72
Top holders
10
TARS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Tarsus Pharmaceuticals, Inc. SEC filings
Tarsus Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87650L103
Recent filing periods:
Ownership snapshot
Top reported holders of TARS - Tarsus Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Vivo Capital IX, LLC
Disclosed value leader
Vivo Capital IX, LLC
Comparable rows
0/15
Latest evidence
30 Jun 2022
3/4/5
13F
Highest disclosed value: $49,380,020
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Vivo Capital IX, LLC has the largest disclosed position value at $49.38M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Vivo Capital IX, LLC's linked filing trail.
Disclosed position value
Top 5
Vivo Capital IX, LLC
$49.38M
RTW INVESTMENTS, LP
$40.27M
Jason E. Tester
$109.9K
Vivo Capital, LLC
$33.76M
TANG CAPITAL MANAGEMENT LLC
$30.43M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Vivo Capital IX, LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$49,380,020
2,469,001 shares
|
— | 05 May 2022 |
| RTW INVESTMENTS, LP |
3/4/5
13F
10%+ Owner · Company
|
—
denominator unverified
|
$40,272,020
2,013,601 shares
|
— | 07 May 2021 |
| Jason E. Tester |
3/4/5
Director, 10%+ Owner
|
—
denominator unverified
|
$109,900
10,000 shares
|
— | 15 Jun 2021 |
| Vivo Capital, LLC |
13F
Company
|
—
denominator unverified
|
$33,761,000
2,312,368 shares
|
— | 30 Jun 2022 |
| TANG CAPITAL MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$30,432,000
2,084,370 shares
|
— | 30 Jun 2022 |
| Cormorant Asset Management, LP |
13F
Company
|
—
denominator unverified
|
$27,375,000
1,875,000 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
72
Shares
20,489,091
Rows available
72
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
70
Q3 2022 holders
72
Holder diff
2
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend